+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oncolytic Virus Manufacturing & Development Services Market - Global Forecast 2025-2030- Product Image
Oncolytic Virus Manufacturing & Development Services Market - Global Forecast 2025-2030- Product Image
Sale

Oncolytic Virus Manufacturing & Development Services Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6116725
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The oncolytic virus manufacturing and development market is transforming oncology by enabling the advancement of targeted cancer therapies through the seamless integration of virology, advanced process engineering, and regulatory rigor. As demand for personalized and scalable solutions continues to rise, manufacturers and biopharma stakeholders face new complexities—and opportunities—across the entire product lifecycle.

Market Snapshot: Oncolytic Virus Manufacturing and Development

As this sector grows, the intersection of specialized manufacturing capabilities and multidisciplinary collaboration is catalyzing a shift from lab validation to viable, patient-ready treatments. Market participants are navigating intensified global demand, evolving compliance landscapes, and a drive for scalable solutions in clinical and commercial production. Key players like Lonza Group AG, Thermo Fisher Scientific Inc., and Catalent, Inc. anchor the competitive environment by combining technological agility with robust quality frameworks. The adoption of modular, single-use bioreactor systems and integrated digital analytics is guiding the industry toward more resilient, efficient production, underpinning a promising outlook for therapeutic breakthroughs.

Scope & Segmentation of Oncolytic Virus Manufacturing Services

  • Service Type: Analytical services enhance assay characterization and product release; cell line development ensures genetic stability; fill & finish maximizes readiness for clinical trials; manufacturing spans clinical, preclinical, and commercial workflows; process development supports optimization; purification maximizes viral purity; quality control validates outputs; regulatory support underpins compliance activities.
  • Scale: Clinical (Phase I/II, Phase III), commercial, and preclinical manufacturing activities guide batch flexibility, process control, and regulatory standards.
  • Virus Type: Adenovirus, herpes simplex virus, measles, Newcastle disease virus, reovirus, and vaccinia platforms each demand unique process expertise and solutions.
  • End User: Academic institutes, biotech innovators, contract research organizations, hospitals, and pharmaceutical companies each fuel distinct demand dynamics and partnership models.
  • Application: Hematological malignancies (leukemia, lymphoma, multiple myeloma) and an array of solid tumor indications (breast, colorectal, lung, melanoma) propel service utilization.
  • Contract Type: Collaborative research, fee-for-service, joint ventures, and license agreements expand engagement options and commercialization pathways.
  • Region: Americas (led by the United States, Canada, Brazil, Mexico, Argentina), EMEA (including United Kingdom, Germany, France, Saudi Arabia, and more), and Asia-Pacific (centered on China, Japan, India, South Korea, Australia, Singapore, and others).

Key Takeaways for Senior Decision-Makers

  • Emerging manufacturing platforms, particularly single-use and modular systems, are redefining operational adaptability and helping reduce contamination risks across production runs.
  • Cutting-edge digital tools—such as digital twins and real-time analytics—enable proactive process monitoring and facilitate greater consistency in product quality.
  • The rise of gene editing and synthetic biology is promoting customizable viral constructs aligned to diverse tumor profiles while broadening the scope of future clinical applications.
  • Collaborative models are evolving, with increased convergence among academic institutes, biotech firms, and contract organizations to deliver flexible, end-to-end solutions for new therapies.
  • Successful companies are leveraging scenario planning and diversified sourcing to navigate regulatory and policy uncertainties efficiently.
  • Regional dynamics—such as infrastructure maturity in the Americas, regulatory harmonization in EMEA, and rapid capacity expansion in Asia-Pacific—shape go-to-market strategies and impact competitive positioning.

Tariff Impact on Cost Structures and Supply Chains

New United States tariffs in 2025 are projected to disrupt global supply chains for oncolytic virus manufacturing. Increased duties on imported bioreactor components and key raw materials may elevate operational costs and pressure companies to accelerate the localization of critical supply points. Stakeholders must reevaluate procurement strategies, form new domestic partnerships, and maintain diversified vendor relationships to strengthen resilience against market volatility. Modular, transportable manufacturing units are likely to gain strategic traction as a result.

Methodology & Data Sources

This study combines a robust mixed-methods approach, integrating secondary research (including scientific literature, patents, and regulatory guidelines) with primary interviews from sector experts and senior executives. Quantitative data are triangulated across corporate disclosures, while qualitative insights undergo expert panel review and validation, ensuring transparency and replicability throughout the analytical process.

Why This Report Matters

  • Supports strategic planning by offering an actionable roadmap for operational efficiency and risk mitigation in oncolytic virus manufacturing.
  • Equips stakeholders with a comprehensive understanding of technological, regulatory, and regional drivers—enabling informed investment and partnership decisions.
  • Facilitates scenario analysis by highlighting evolving tariff impacts, regional market entries, and the emergence of flexible manufacturing solutions.

Conclusion

Oncolytic virus manufacturing is at a pivotal intersection of science, technology, and regulation, with agile strategies and collaborative frameworks shaping its future. This report offers clear insights to navigate complexity, optimize operations, and advance next-generation cancer therapies.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of continuous bioprocessing platforms for scalable oncolytic virus production
5.2. Integration of single-use bioreactors to accelerate manufacturing timelines in oncolytic therapies
5.3. Implementation of advanced process analytical technologies for real-time monitoring of virus yield and purity
5.4. Collaboration between contract development organizations and academic centers to optimize viral vector platforms
5.5. Investment in high-throughput upstream screening to identify optimal cell lines for oncolytic virus propagation
5.6. Development of robust downstream purification workflows to enhance viral potency and safety profiles
5.7. Regulatory harmonization initiatives focused on streamlining approval pathways for engineered oncolytic viruses
5.8. Adoption of modular facility design for flexible scale-up of oncolytic virus production capacity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Oncolytic Virus Manufacturing & Development Services Market, by Service Type
8.1. Introduction
8.2. Analytical Services
8.3. Cell Line Development
8.4. Fill & Finish
8.5. Manufacturing
8.5.1. Clinical Manufacturing
8.5.1.1. Phase I/II Manufacturing
8.5.1.2. Phase III Manufacturing
8.5.2. Commercial Manufacturing
8.5.3. Preclinical Manufacturing
8.6. Process Development
8.7. Purification
8.8. Quality Control
8.9. Regulatory Support
9. Oncolytic Virus Manufacturing & Development Services Market, by Scale
9.1. Introduction
9.2. Clinical
9.2.1. Phase I/II
9.2.2. Phase III
9.3. Commercial
9.4. Preclinical
10. Oncolytic Virus Manufacturing & Development Services Market, by Virus Type
10.1. Introduction
10.2. Adenovirus
10.3. Herpes Simplex Virus
10.4. Measles Virus
10.5. Newcastle Disease Virus
10.6. Reovirus
10.7. Vaccinia Virus
11. Oncolytic Virus Manufacturing & Development Services Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Biotech Companies
11.4. Contract Research Organizations
11.5. Hospitals
11.6. Pharmaceutical Companies
12. Oncolytic Virus Manufacturing & Development Services Market, by Application
12.1. Introduction
12.2. Hematological Malignancies
12.2.1. Leukemia
12.2.2. Lymphoma
12.2.3. Multiple Myeloma
12.3. Solid Tumors
12.3.1. Breast Cancer
12.3.2. Colorectal Cancer
12.3.3. Lung Cancer
12.3.4. Melanoma
13. Oncolytic Virus Manufacturing & Development Services Market, by Contract Type
13.1. Introduction
13.2. Collaborative Research
13.3. Fee-for-Service
13.4. Joint Ventures
13.5. License Agreements
14. Americas Oncolytic Virus Manufacturing & Development Services Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Oncolytic Virus Manufacturing & Development Services Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Oncolytic Virus Manufacturing & Development Services Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Lonza Group AG
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. Catalent, Inc.
17.3.4. Merck KGaA
17.3.5. Danaher Corporation
17.3.6. WuXi AppTec Co., Ltd.
17.3.7. Fujifilm Diosynth Biotechnologies
17.3.8. AGC Biologics, Inc.
17.3.9. Sartorius AG
17.3.10. Oxford Biomedica plc
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET: RESEARCHAI
FIGURE 28. ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 29. ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET: RESEARCHCONTACTS
FIGURE 30. ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY FILL & FINISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY FILL & FINISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHASE I/II MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHASE I/II MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHASE III MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHASE III MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PRECLINICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PRECLINICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PURIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY REGULATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY REGULATORY SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHASE I/II, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHASE I/II, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY ADENOVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY ADENOVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HERPES SIMPLEX VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HERPES SIMPLEX VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MEASLES VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MEASLES VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY NEWCASTLE DISEASE VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY NEWCASTLE DISEASE VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY REOVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY REOVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VACCINIA VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VACCINIA VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COLLABORATIVE RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COLLABORATIVE RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY FEE-FOR-SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY FEE-FOR-SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY JOINT VENTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY JOINT VENTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY LICENSE AGREEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY LICENSE AGREEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 163. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 164. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 165. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 166. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 167. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 168. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 169. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 170. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 171. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 172. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 173. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2018-2024 (USD MILLION)
TABLE 174. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2025-2030 (USD MILLION)
TABLE 175. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 180. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 181. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 182. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 183. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 184. CANADA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 188. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 189. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 190. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 191. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 194. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 195. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 203. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 206. MEXICO ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY VIRUS TYPE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ONCOLYTIC VIRUS MANUFACTURING & DEVELOPMENT SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2

Companies Mentioned

The companies profiled in this Oncolytic Virus Manufacturing & Development Services market report include:
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • Merck KGaA
  • Danaher Corporation
  • WuXi AppTec Co., Ltd.
  • Fujifilm Diosynth Biotechnologies
  • AGC Biologics, Inc.
  • Sartorius AG
  • Oxford Biomedica plc

Related Topics

Related Reports

Oncolytic Virus Cancer Therapy Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Oncolytic Virus Cancer Therapy Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Oncolytic Virus Therapies Market Report by Virus Type, Application, End Use, and Region 2025-2033 - Product Image

Oncolytic Virus Therapies Market Report by Virus Type, Application, End Use, and Region 2025-2033

  • Report
  • 133 Pages
  • Global
From
Oncolytic Virus Therapies Market - Global Forecast 2025-2032 - Product Image

Oncolytic Virus Therapies Market - Global Forecast 2025-2032

  • Report
  • 189 Pages
  • Global
From
Oncolytic Virus Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Oncolytic Virus Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Oncolytic Virus Immunotherapy - Global Strategic Business Report - Product Image

Oncolytic Virus Immunotherapy - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.